Neuralstem Reports Second Quarter 2017 Fiscal Results and Provides Clinical and Business Update Aug 8, 2017
Neuralstem Awarded $~1MM Grant by NIH to Continue Preclinical Research into the Potential of NSI-189 for Treatment of Diabetic Neuropathy Aug 2, 2017
Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder May 17, 2017
Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update May 10, 2017